Cited by 18Cardiac electrophysiology and arrhythmiasCardiac pacing and defibrillation studiesCardiac Arrhythmias and Treatments

Usefulness of Microvolt T-Wave Alternans to Predict Outcomes in Patients With Ischemic Cardiomyopathy Beyond One Year

Chan, Paul S., Kereiakes, Dean J., Bartone, Cheryl, Chow, Theodore·2008·The American Journal of Cardiology

Abstract

Previous studies have demonstrated that microvolt T-wave alternans (MTWA) screening effectively risk-stratifies patients with ischemic cardiomyopathy. Whether the prognostic utility of MTWA diminishes over 3 years of follow-up remains unknown. In this study, a prospective cohort of 768 patients with ischemic cardiomyopathy (left ventricular ejection fraction <35%) and no previous sustained ventricular arrhythmia was developed, of whom 514 (67%) screened MTWA nonnegative (positive and indeterminate). The mean follow-up period was 18 +/- 11 months. The primary end point was all-cause mortality and appropriate implantable cardioverter-defibrillator shocks. Stratified Cox regression analyses (by implantable cardioverter-defibrillator status) estimated the predictive power of MTWA within each year of follow-up and determined whether this diminished over time. There were 99 deaths (MTWA negative: 21 [8.3%]; MTWA nonnegative: 78 [15.2%]) and 33 appropriate implantable cardioverter-defibrillator shocks (MTWA negative: 3 [4.0%]; MTWA nonnegative: 30 [9.5%]). After multivariate adjustment, a nonnegative MTWA test result was associated with a greater than twofold increased risk for events in each of the 3 years of follow-up (year 1: stratified hazard ratio 2.19, 95% confidence interval 1.10 to 4.34, p = 0.03; year 2: stratified hazard ratio 3.36, 95% confidence interval 1.28 to 8.83, p = 0.01; year 3: stratified hazard ratio 2.06, 95% confidence interval 0.81 to 5.22, p = 0.13). There were no significant interactions between the time periods (year 1 vs year 2: p = 0.47; year 1 vs year 3: p = 0.92). In conclusion, MTWA reliably and consistently predicts mortality and arrhythmic risk throughout the first 2 to 3 years of follow-up. Although these findings need further validation, they suggest that rescreening with MTWA may not need to be performed more frequently than once every 2 years.

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2008.03.049

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The utility for mortality prediction and arrhythmic risk evaluation of microvolt T-wave alternans was demonstrated in ischemic cardiomyopathy.

    “The utility for mortality prediction and arrhythmic risk evaluation of microvolt T-wave alternans was demonstrated in ischemic cardiomyopathy.41”

    From The Year of 2008 in Electrocardiology (2010) · cites this paper as [41]

Cites

Flagged first, then by citations

1 of the 20 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Chan, P. S., Kereiakes, D. J., Bartone, C., & Chow, T.
Affiliations
  • University of Missouri–Kansas City (US)
  • Christ Hospital (US)
Corresponding author
Chan, Paul S.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2008-08
Volume
102
Issue
3
Pages
280-284
ISSN
0002-9149 (ISSN-L)
OpenAlex
W2160809434
Cited by
18
References
20
Citations by year
2023: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 3 · 2013: 1 · 2012: 2
FWCI
1.94
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Medical School, University of Michigan
  • National Institutes of Health
  • Medtronic
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords
microvolt T-wave alternans, ischemic cardiomyopathy, prognosis, all-cause mortality, implantable cardioverter-defibrillator shocks, ventricular arrhythmia risk, risk stratification, left ventricular ejection fraction
MeSH terms
Aged, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Cardiomyopathies, Regression Analysis, Defibrillators, Implantable, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review